Skip to main content
. 2015 Apr 27;10(4):e0124169. doi: 10.1371/journal.pone.0124169

Table 6. Comparison of 5 dimensions according to the presence or absence of individual adverse events.

Adverse events Mobility Personal care Usual activities Pain/discomfort Anxiety/depression
Grade n Some or major problems (%) Deteriorated (%) p Some or major problems (%) Deteriorated (%) p Some or major problems (%) Deteriorated (%) p Some or major problems (%) Deteriorated (%) p Some or major problems (%) Deteriorated (%) p
Before CT After CT Before CT After CT Before CT After CT Before CT After CT Before CT After CT
Alopecia 1.000 1.000 0.008* 0.036* 0.739
0 16 18.8 37.5 18.8 12.5 18.8 6.3 18.8 25.0 6.3 43.8 37.5 6.3 31.3 56.3 31.3
1–3 31 6.5 25.8 19.4 3.2 9.7 6.5 6.5 45.2 45.2 41.9 58.1 38.7 45.2 51.6 25.8
Nail ridging 1.000 0.292 0.648 0.607 1.000
0 42 11.9 31.0 19.0 7.1 11.9 4.8 11.9 38.1 31.0 40.5 47.6 26.2 40.5 52.4 28.6
1–3 5 0.0 20.0 20.0 0.0 20.0 20.0 0.0 40.0 40.0 60.0 80.0 40.0 40.00 60.00 20.0
Dry skin 0.605 0.391 1.000 0.377 1.000
0 40 10.0 27.5 17.5 5.0 10.0 5.00 10.0 37.5 32.5 40.0 45.0 25.0 37.5 50.0 27.5
1–3 7 14.3 42.9 28.6 14.3 28.6 14.3 14.3 42.9 28.6 57.1 85.7 42.9 57.14 71.43 28.6
Nausea 0.412 0.560 0.158 1.000 0.269
0 35 11.4 34.3 22.9 8.6 17.1 8.6 11.4 34.3 25.7 42.9 54.3 28.6 42.9 48.6 22.9
1–3 12 8.3 16.8 8.3 0.0 0.0 0.0 8.3 50.0 50.0 41.67 41.67 25.0 33.33 66.67 41.7
Constipation 0.466 0.264 0.019* 0.096 0.168
0 31 12.9 29.0 16.1 6.5 9.7 3.2 16.1 29.0 19.4 41.9 41.9 19.4 32.3 61.3 35.5
1–3 16 6.3 31.3 25.0 6.3 18.8 12.5 0.0 56.3 56.3 43.8 68.8 43.8 56.3 37.5 12.5
Mucositis oral 0.205 0.560 1.000 0.065 0.713
0 35 11.4 25.7 14.3 5.7 14.3 8.6 11.4 37.1 31.4 48.6 45.7 20.0 37.1 48.6 25.7
1–3 12 8.3 41.6 33.3 8.3 8.3 0.0 8.3 41.7 33.3 25.0 66.7 50.0 50.0 66.7 33.3
Oral pain 1.000 0.292 0.309 0.607 0.607
0 42 9.5 28.6 19.0 7.1 11.9 4.8 11.9 35.7 28.6 40.5 50.0 26.2 38.1 50.0 26.2
1–3 5 20.0 40.0 20.0 0.0 20.0 20.0 0.0 60.0 60.0 60.0 60.0 40.0 60.0 80.0 40.0
Peripheral sensory neuropathy 1.000 1.000 1.000 0.692 1.000
0 38 5.3 23.7 18.4 2.6 10.5 7.9 10.5 36.8 31.6 39.5 50.0 26.3 36.8 47.4 28.9
1–3 9 33.3 55.6 22.2 22.2 22.2 0.0 11.1 44.4 33.3 55.6 55.6 33.3 55.56 77.78 22.2
Dysgeusia 1.000 1.000 0.246 0.413 1.000
0 39 12.8 33.3 20.5 7.7 15.4 7.7 12.8 35.9 28.2 43.6 53.8 30.8 41.0 53.8 28.2
1–3 8 0.0 12.5 12.5 0.0 0.0 0.0 0.0 50.0 50.0 37.5 37.5 12.5 37.5 50.0 25.0
Malaise 0.711 1.000 0.028* 0.744 0.746
0 21 9.5 23.8 14.3 4.8 9.5 4.8 14.3 23.8 14.3 33.3 47.6 28.6 28.6 38.1 23.8
1–3 26 11.5 34.6 23.1 7.7 15.4 7.7 7.7 50.0 46.2 50.0 53.9 23.1 50.0 65.4 30.8
Fever 0.318 1.000 0.188 1.000 1.000
0 40 10.0 32.5 22.5 5.0 12.5 7.5 12.5 35.0 27.5 40.0 47.5 27.5 37.5 50.0 27.5
1–3 7 14.3 14.3 0.0 14.3 14.3 0.0 0.0 57.1 57.1 57.1 71.4 28.6 57.1 71.4 28.6
White blood cell decreased 1.000 1.000 0.465 0.703 1.000
0 37 13.5 32.4 18.9 8.1 16.2 8.1 10.8 43.2 35.1 40.5 54.1 29.7 40.5 56.8 27.0
1–3 10 0.0 20.0 20.0 0.00 0.00 0.0 10.0 20.0 20.0 50.0 40.0 20.0 40.0 40.0 20.0
Anemia 0.716 1.000 0.202 1.000 0.315
0 29 13.8 31.0 17.2 6.9 13.8 6.9 10.3 34.5 24.1 34.5 48.3 27.6 31.0 55.2 34.5
1–3 18 5.6 27.8 22.2 5.6 11.1 5.6 11.1 44.4 44.4 55.6 55.6 27.8 55.6 50.0 16.7
Anorexia 0.142 0.567 0.030* 1.000 0.511
0 27 14.8 25.9 11.1 7.4 11.1 3.7 18.5 29.6 18.5 44.4 55.6 25.9 40.7 40.7 22.2
1–3 20 5.0 35.0 30.0 5.0 15.0 10.0 0.0 50.0 50.0 40.0 45.0 30.0 40.0 70.0 35.0

CT: chemotherapy,

*p<0.05